Working on a deal now valued at 4.5x -5x which we think is within market range (industry comps are 4-6x).
However when we look at purchase price allocation across the balance sheet, the write up of PP&E creates significant negative goodwill...thus the purchase price is lower than the FMV of the assets + equity of the company.
Does this suggest that our EBITDA multiple and corresponding valuation is below market and thus not competitive?